Scoville Steven D, Xourafas Dimitrios, Ejaz Aslam M, Tsung Allan, Pawlik Timothy, Cloyd Jordan M
Department of Surgery, Division of Surgical Oncology at The Ohio State University, James Cancer Center, Columbus, OH 43210, United States.
World J Gastrointest Surg. 2020 Apr 27;12(4):159-170. doi: 10.4240/wjgs.v12.i4.159.
Although surgical resection is associated with the best long-term outcomes for neuroendocrine liver metastases (NELM), the current indications for and outcomes of surgery for NELM from a population perspective are not well understood.
To determine the current indications for and outcomes of liver resection (LR) for NELM using a population-based cohort.
A retrospective review of the 2014-2017 American College of Surgeons National Surgical Quality Improvement Program and targeted hepatectomy databases was performed to identify patients who underwent LR for NELM. Perioperative characteristics and 30-d morbidity and mortality were analyzed.
Among 669 patients who underwent LR for NELM, the median age was 60 (interquartile range: 51-67) and 51% were male. While the number of metastases resected ranged from 1 to 9, the most common (45%) number of tumors resected was one. The majority (68%) of patients had a largest tumor size of < 5 cm. Most patients underwent partial hepatectomy (71%) while fewer underwent a right or left hepatectomy or trisectionectomy. The majority of operations were open (82%) versus laparoscopic (17%) or robotic (1%). In addition, 30% of patients underwent intraoperative ablation while 45% had another concomitant operation including cholecystectomy (28.8%), bowel resection (20.2%), or partial pancreatectomy (3.4%). Overall 30-d morbidity and mortality was 29% and 1.3%, respectively. On multivariate analysis, American Society of Anesthesiologists class ≥ 3 [odds ratios (OR), OR = 2.089, 95% confidence intervals (CI): 1.197-3.645], open approach (OR = 1.867, 95%CI: 1.148-3.036), right hepatectomy (OR = 1.618, 95%CI: 1.014-2.582), and prolonged operative time of > 230 min (OR = 1.731, 95%CI: 1.168-2.565) were associated with higher 30-d morbidity while intraoperative ablation and concomitant procedures were not.
LR for NELM was performed with relatively low postoperative morbidity and mortality. Concomitant procedures performed at the time of LR did not increase morbidity.
尽管手术切除对于神经内分泌肝转移瘤(NELM)具有最佳的长期预后,但从人群角度来看,目前NELM手术的适应证和手术效果尚不清楚。
使用基于人群的队列研究来确定NELM肝切除术(LR)的当前适应证和手术效果。
对2014 - 2017年美国外科医师学会国家外科质量改进计划和靶向肝切除术数据库进行回顾性分析,以确定接受NELM的LR患者。分析围手术期特征以及30天的发病率和死亡率。
在669例接受NELM的LR患者中,中位年龄为60岁(四分位间距:51 - 67岁),51%为男性。切除的转移瘤数量范围为1至9个,最常见(45%)的切除肿瘤数量为1个。大多数(68%)患者最大肿瘤直径<5 cm。大多数患者接受了肝部分切除术(71%),而接受右半肝或左半肝切除术或肝三叶切除术的患者较少。大多数手术为开放手术(82%),而腹腔镜手术(17%)或机器人手术(1%)较少。此外,30%的患者在术中进行了消融,45%的患者同时进行了其他手术,包括胆囊切除术(28.8%)、肠切除术(20.2%)或胰腺部分切除术(3.4%)。总体30天发病率和死亡率分别为29%和1.3%。多因素分析显示,美国麻醉医师协会分级≥3级[比值比(OR),OR =
2.089,95%置信区间(CI):1.197 - 3.645]、开放手术方式(OR = 1.867,95%CI:1.148 - 3.036)、右半肝切除术(OR = 1.618,95%CI:1.014 - 2.582)以及手术时间延长>230分钟(OR = 1.731,95%CI:1.168 - 2.565)与30天较高的发病率相关,而术中消融和同期手术则无此关联。
NELM的LR术后发病率和死亡率相对较低。LR时同期进行的手术并未增加发病率。